Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
$12.80
+1.9%
$16.14
$5.11
$19.22
$353.69M1.06208,759 shs150,942 shs
electroCore, Inc. stock logo
ECOR
electroCore
$8.56
-10.4%
$15.84
$5.32
$19.49
$56.98M0.2464,782 shs278,991 shs
Nyxoah S.A. stock logo
NYXH
Nyxoah
$10.51
+4.6%
$10.29
$6.76
$20.00
$357.97M1.4242,835 shs184,921 shs
ZimVie Inc. stock logo
ZIMV
ZimVie
$12.04
+0.5%
$13.50
$11.62
$22.40
$333.23M2.1238,160 shs163,566 shs
7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
+1.91%-2.07%-29.01%-16.48%+78.52%
electroCore, Inc. stock logo
ECOR
electroCore
-10.37%-39.29%-48.53%-37.11%+32.71%
Nyxoah S.A. stock logo
NYXH
Nyxoah
+4.58%+5.00%0.00%+31.38%-38.65%
ZimVie Inc. stock logo
ZIMV
ZimVie
+0.50%-4.06%-7.38%-12.31%-28.25%
Remove Ads
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
2.2354 of 5 stars
3.53.00.00.02.90.00.6
electroCore, Inc. stock logo
ECOR
electroCore
2.1168 of 5 stars
3.53.00.00.01.60.80.6
Nyxoah S.A. stock logo
NYXH
Nyxoah
2.1592 of 5 stars
3.53.00.00.01.70.80.6
ZimVie Inc. stock logo
ZIMV
ZimVie
2.0302 of 5 stars
3.03.00.00.01.91.70.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
3.00
Buy$25.0095.31% Upside
electroCore, Inc. stock logo
ECOR
electroCore
3.00
Buy$25.50197.90% Upside
Nyxoah S.A. stock logo
NYXH
Nyxoah
3.00
Buy$15.2545.10% Upside
ZimVie Inc. stock logo
ZIMV
ZimVie
2.00
Hold$23.0091.03% Upside

Current Analyst Ratings Breakdown

Latest ECOR, CLPT, ZIMV, and NYXH Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/14/2025
Nyxoah S.A. stock logo
NYXH
Nyxoah
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$16.00 ➝ $15.00
3/13/2025
electroCore, Inc. stock logo
ECOR
electroCore
LADENBURG THALM/SH SH
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$28.00 ➝ $26.00
3/13/2025
electroCore, Inc. stock logo
ECOR
electroCore
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$25.00 ➝ $25.00
3/13/2025
ZimVie Inc. stock logo
ZIMV
ZimVie
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Hold
2/27/2025
ZimVie Inc. stock logo
ZIMV
ZimVie
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$23.00 ➝ $23.00
1/28/2025
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$15.00 ➝ $20.00
1/21/2025
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
Lake Street Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$17.00 ➝ $30.00
12/18/2024
electroCore, Inc. stock logo
ECOR
electroCore
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$22.00 ➝ $25.00
(Data available from 3/15/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
$31.39M11.27N/AN/A$0.86 per share14.88
electroCore, Inc. stock logo
ECOR
electroCore
$23.33M2.44N/AN/A$1.24 per share6.90
Nyxoah S.A. stock logo
NYXH
Nyxoah
$5.08M70.44N/AN/AN/A
ZimVie Inc. stock logo
ZIMV
ZimVie
$449.75M0.74$4.35 per share2.77$15.43 per share0.78
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
-$22.09M-$0.70N/AN/AN/A-59.64%-62.10%-38.39%5/6/2025 (Estimated)
electroCore, Inc. stock logo
ECOR
electroCore
-$18.83M-$1.62N/AN/AN/A-54.40%-154.45%-69.16%5/6/2025 (Estimated)
Nyxoah S.A. stock logo
NYXH
Nyxoah
-$46.77M-$1.87N/AN/AN/A-1,043.93%-51.68%-40.11%5/13/2025 (Estimated)
ZimVie Inc. stock logo
ZIMV
ZimVie
-$393.28M-$0.95N/AN/A-77.31%2.90%1.17%5/14/2025 (Estimated)

Latest ECOR, CLPT, ZIMV, and NYXH Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
3/13/2025Q4 2024
Nyxoah S.A. stock logo
NYXH
Nyxoah
-$0.46-$0.49-$0.03-$0.49$2.02 millionN/A
2/26/2025Q4 2024
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
-$0.15-$0.20-$0.05-$0.20$8.23 million$7.77 million
2/26/2025Q4 2024
ZimVie Inc. stock logo
ZIMV
ZimVie
$0.25$0.27+$0.02-$0.43$113.67 million$111.52 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
N/AN/AN/AN/AN/A
electroCore, Inc. stock logo
ECOR
electroCore
N/AN/AN/AN/AN/A
Nyxoah S.A. stock logo
NYXH
Nyxoah
N/AN/AN/AN/AN/A
ZimVie Inc. stock logo
ZIMV
ZimVie
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
N/A
4.54
3.61
electroCore, Inc. stock logo
ECOR
electroCore
N/A
2.12
1.87
Nyxoah S.A. stock logo
NYXH
Nyxoah
0.21
5.28
4.95
ZimVie Inc. stock logo
ZIMV
ZimVie
0.57
1.94
1.38

Institutional Ownership

CompanyInstitutional Ownership
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
30.08%
electroCore, Inc. stock logo
ECOR
electroCore
26.74%
Nyxoah S.A. stock logo
NYXH
Nyxoah
N/A
ZimVie Inc. stock logo
ZIMV
ZimVie
95.63%

Insider Ownership

CompanyInsider Ownership
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
6.11%
electroCore, Inc. stock logo
ECOR
electroCore
19.70%
Nyxoah S.A. stock logo
NYXH
Nyxoah
17.11%
ZimVie Inc. stock logo
ZIMV
ZimVie
3.01%
CompanyEmployeesShares OutstandingFree FloatOptionable
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
11027.63 million25.90 millionOptionable
electroCore, Inc. stock logo
ECOR
electroCore
506.66 million5.35 millionNot Optionable
Nyxoah S.A. stock logo
NYXH
Nyxoah
11034.06 million28.23 millionNot Optionable
ZimVie Inc. stock logo
ZIMV
ZimVie
2,70027.68 million26.77 millionOptionable

Recent News About These Companies

ZimVie shuffles board of directors
Needham Downgrades ZimVie (ZIMV)
ZimVie downgraded to Hold from Buy at Needham
ZimVie Announces Upcoming Changes to Company's Board of Directors
Dental technology updates to know from February
Q4 2024 ZimVie Inc Earnings Call
ZimVie records $9.7M net loss in Q4: 6 things to know
ZimVie: Making Some Progress
ZimVie Inc. stock logo
ZimVie (NASDAQ:ZIMV) Updates FY 2025 Earnings Guidance
ZimVie reports Q4 adjusted EPS 27c, consensus 26c

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
ClearPoint Neuro stock logo

ClearPoint Neuro NASDAQ:CLPT

$12.80 +0.24 (+1.91%)
Closing price 03/14/2025 04:00 PM Eastern
Extended Trading
$12.82 +0.02 (+0.16%)
As of 03/14/2025 06:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain. It has license and collaboration agreement with Clinical Laserthermia Systems AB; license and research agreement with Koninklijke Philips N.V., UCB Biopharma SRL, and University of California and San Francisco; and development and license agreement with NE Scientific, LLC. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.

electroCore stock logo

electroCore NASDAQ:ECOR

$8.56 -0.99 (-10.37%)
Closing price 03/14/2025 04:00 PM Eastern
Extended Trading
$8.52 -0.04 (-0.41%)
As of 03/14/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

electroCore, Inc., a commercial stage bioelectronic medicine and wellness company, provides non-invasive vagus nerve stimulation technology platform in the United States, the United Kingdom, and internationally. The company is developing gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania. It also develops Truvaga for the support of general health and wellbeing; and TAC-STIM for human performance. In addition, the company offers gammacore Sapphire, a portable, reusable, rechargeable, and reloadable prescription medical device for various primary headache conditions. electroCore, Inc. was incorporated in 2005 and is headquartered in Rockaway, New Jersey.

Nyxoah stock logo

Nyxoah NASDAQ:NYXH

$10.51 +0.46 (+4.58%)
Closing price 03/14/2025 03:59 PM Eastern
Extended Trading
$10.78 +0.27 (+2.52%)
As of 03/14/2025 05:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company's lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah S.A. was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.

ZimVie stock logo

ZimVie NASDAQ:ZIMV

$12.04 +0.06 (+0.50%)
Closing price 03/14/2025 04:00 PM Eastern
Extended Trading
$12.04 0.00 (0.00%)
As of 03/14/2025 04:23 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ZimVie Inc., together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment. The company offers dental implant systems, prosthetic and abutment products, surgical instrumentation, and kits; and patient-specific restorative solutions, such as abutments, bars, implant bridges, and hybrid restorations under the BellaTek brand name. It provides bone grafts, barrier membranes, and collagen wound care products; virtual treatment planning services, guided surgery solutions, CAD/CAM workflow systems, and intra-oral scanners; and Implant Concierge, a web-based treatment planning and surgery guide service. In addition, the company designs, manufactures, and distributes spinal fusion implants, instrumentation for various spinal procedures, biologics, and bone healing technologies. Further, it provides MIS solutions that deliver implant and instrumentation systems; and motion preservation solutions that offer non-fusion alternatives for cervical disc implant or growth modulation for anterior vertebral body tethering. The company sells its products to oral surgeons, dental specialists, general dentists, dental laboratories, and other dental organizations, including DSOs, as well as educational, medical, and governmental entities, hospitals, and surgery centers through direct sales representatives, agents, and distributors. ZimVie Inc. was incorporated in 2021 and is headquartered in Westminster, Colorado.